Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nabriva Therapeutics AG | 35,000 | reported | 29 Jul 2020 | tx 25+143,685−3,490 |
| Nabriva Therapeutics Plc | 31,790 | reported | 23 Jun 2017 | tx 3+81,890 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Jul 2020 | GRANT_AWARD | Nabriva Therapeutics AG | 17,500 | 0.00 USD | |
| 29 Jul 2020 | GRANT_AWARD | Nabriva Therapeutics AG | 35,000 | 0.00 USD | deriv |
| 31 Jul 2019 | GRANT_AWARD | Nabriva Therapeutics AG | 35,000 | 0.00 USD | deriv |
| 31 Jul 2018 | PURCHASE | Nabriva Therapeutics AG | 14,500 | 2.75 USD | |
| 02 May 2018 | GRANT_AWARD | Nabriva Therapeutics AG | 29,000 | 0.00 USD | deriv |
| 27 Sept 2017 | EXERCISE | Nabriva Therapeutics AG | 1,350 | — | |
| 27 Sept 2017 | EXERCISE | Nabriva Therapeutics AG | 1,350 | 0.00 USD | deriv |
| 15 Sept 2017 | GRANT_AWARD | Nabriva Therapeutics AG | 10,100 | 0.00 USD | deriv |
| 23 Jun 2017 | OTHER | Nabriva Therapeutics Plc | 31,790 | 0.00 USD | |
| 23 Jun 2017 | OTHER | Nabriva Therapeutics Plc | 10,100 | 0.00 USD | deriv |
| 23 Jun 2017 | OTHER | Nabriva Therapeutics Plc | 40,000 | 0.00 USD | deriv |
| 16 Jun 2017 | SALE | Nabriva Therapeutics AG | 24 | 93.50 USD | |
| 15 Jun 2017 | SALE | Nabriva Therapeutics AG | 100 | 94.10 USD | |
| 19 Jun 2017 | SALE | Nabriva Therapeutics AG | 46 | 91.00 USD | |
| 30 May 2017 | SALE | Nabriva Therapeutics AG | 100 | 101.00 USD | |
| 30 May 2017 | SALE | Nabriva Therapeutics AG | 110 | 101.50 USD | |
| 23 May 2017 | SALE | Nabriva Therapeutics AG | 30 | 99.70 USD | |
| 25 May 2017 | SALE | Nabriva Therapeutics AG | 205 | 100.50 USD | |
| 25 May 2017 | SALE | Nabriva Therapeutics AG | 90 | 101.00 USD | |
| 16 May 2017 | SALE | Nabriva Therapeutics AG | 100 | 103.00 USD | |
| 16 Feb 2017 | EXERCISE | Nabriva Therapeutics AG | 155 | — | |
| 16 Feb 2017 | EXERCISE | Nabriva Therapeutics AG | 502 | — | |
| 16 May 2017 | SALE | Nabriva Therapeutics AG | 50 | 102.27 USD | |
| 16 Feb 2017 | EXERCISE | Nabriva Therapeutics AG | 578 | — | |
| 15 May 2017 | SALE | Nabriva Therapeutics AG | 50 | 101.50 USD |